NCT05134350View on ClinicalTrials.gov

Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 6, 2020

Primary Completion Date

March 23, 2020

Study Completion Date

March 23, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

LOXO-305

LOXO-305 orally.

DRUG

Omeprazole

Omeprazole Orally.

Trial Locations (1)

32117

Covance Clinical Research Unit, Daytona Beach

Sponsors
All Listed Sponsors
lead

Loxo Oncology, Inc.

INDUSTRY